ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
70,235
0,00%
Bitcoin
84 951,72
-1,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Northwest Biotherapeutics Inc (QB) (NWBO) Cours

Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

USOTC
0,251
-0,00067
(-0,26%)
Fermé 09 Mars 9:00PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,251
Prix Achat
0,2501
Prix Vente
0,252
Volume échangé
2 161 419
0,25 Fourchette du Jour 0,27
0,24 Plage de 52 semaines 0,6489
Cap du marché
325,659M
Clôture Veille
0,251665
Ouverture
0,255
Dernière Transaction
4000
@
0.251
Dernière heure de transaction
Volume financier
US$ 547 342
VWAP
0,253233
Volume moyen (3 m)
3 473 088
Actions en circulation
1 297 445 623
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,43
Bénéfice par action (BPA)
-0,05
Chiffre d'affairess
1,93M
Bénéfice net
-64,37M

À propos de Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Northwest Biotherapeutics Inc (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker NWBO. Le dernier cours de clôture d'Northwest Biotherapeutics (QB) était de US$0,25. Au cours de la dernière année, les actions de Northwest Biotherapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,24 à US$ 0,6489.

Northwest Biotherapeutics (QB) compte actuellement 1 297 445 623 actions en circulation. La capitalisation boursière d'Northwest Biotherapeutics (QB) est de US$326,52 million. Northwest Biotherapeutics (QB) a un ratio cours/bénéfice (ratio PE) de -3.43.

NWBO Dernières nouvelles

Plus de nouvelles

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
26 Décembre 2024
NWBO (-0,26%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Décembre 2024
NWBO (-0,26%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
12 Novembre 2024
NWBO (-0,26%)

Form 8-K - Current report
Edgar (US Regulatory)
01 Novembre 2024
NWBO (-0,26%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Septembre 2024
NWBO (-0,26%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 Août 2024
NWBO (-0,26%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
09 Août 2024
NWBO (-0,26%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 Août 2024
NWBO (-0,26%)

Form 8-K - Current report
Edgar (US Regulatory)
02 Août 2024
NWBO (-0,26%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
31 Juillet 2024
NWBO (-0,26%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.022-8.058608058610.2730.310.243560550090.27114976CS
4-0.0205-7.550644567220.27150.310.2441335370.26176974CS
12-0.0491-16.3612129290.30010.3580.2434730880.27172919CS
26-0.0489-16.3054351450.29990.3580.2427330830.28081476CS
52-0.3256-56.46895594870.57660.64890.2423307560.34137307CS
156-0.563-69.16461916460.8142.050.2422674650.62783796CS
2600.051125.56278139070.19992.540.00525055090.81529043CS

NWBO - Frequently Asked Questions (FAQ)

What is the current Northwest Biotherapeutics (QB) share price?
The current share price of Northwest Biotherapeutics (QB) is US$ 0,251
How many Northwest Biotherapeutics (QB) shares are in issue?
Northwest Biotherapeutics (QB) has 1 297 445 623 shares in issue
What is the market cap of Northwest Biotherapeutics (QB)?
The market capitalisation of Northwest Biotherapeutics (QB) is USD 326,52M
What is the 1 year trading range for Northwest Biotherapeutics (QB) share price?
Northwest Biotherapeutics (QB) has traded in the range of US$ 0,24 to US$ 0,6489 during the past year
What is the PE ratio of Northwest Biotherapeutics (QB)?
The price to earnings ratio of Northwest Biotherapeutics (QB) is -3,43
What is the cash to sales ratio of Northwest Biotherapeutics (QB)?
The cash to sales ratio of Northwest Biotherapeutics (QB) is 113,33
What is the reporting currency for Northwest Biotherapeutics (QB)?
Northwest Biotherapeutics (QB) reports financial results in USD
What is the latest annual turnover for Northwest Biotherapeutics (QB)?
The latest annual turnover of Northwest Biotherapeutics (QB) is USD 1,93M
What is the latest annual profit for Northwest Biotherapeutics (QB)?
The latest annual profit of Northwest Biotherapeutics (QB) is USD -64,37M
What is the registered address of Northwest Biotherapeutics (QB)?
The registered address for Northwest Biotherapeutics (QB) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does Northwest Biotherapeutics (QB) operate in?
Northwest Biotherapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TBLTToughBuilt Industries Inc (CE)
US$ 2,00
(399 900,00%)
1,46k
SBESSouth Beach Spirits Inc (CE)
US$ 0,0004
(39 900,00%)
5,01M
HBRMHerborium Group Inc (PK)
US$ 0,0001
(9 900,00%)
500k
NXTPNextPlay Technologies Inc (CE)
US$ 0,0001
(9 900,00%)
3,56k
REFGMedical Cannabis Payment Solutions (CE)
US$ 0,0001
(9 900,00%)
121,36k
ZPTAZapata Computing Holdings Inc (CE)
US$ 0,000001
(-99,98%)
12,98k
NPHCNutra Pharma Corp (CE)
US$ 0,000001
(-99,50%)
125
PRSTPresto Automation Inc (CE)
US$ 0,000001
(-99,50%)
200
KPOCKimberly Parry Organics Corporation (CE)
US$ 0,000001
(-99,00%)
500
AMLHAmerican Leisure Holdings Inc (PK)
US$ 0,000001
(-99,00%)
1,3M
HMBLHUMBL Inc (PK)
US$ 0,0004
(14,29%)
199,46M
TKMOTekumo Inc (PK)
US$ 0,0001
(-50,00%)
141,54M
LVGILimitless Venture Group Inc (PK)
US$ 0,0003
(-40,00%)
135,49M
IJJPIJJ Corporation (PK)
US$ 0,0003
(-14,29%)
123,27M
CGACCode Green Apparel Corp (PK)
US$ 0,0003
(-25,00%)
100,12M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
NWBO
Northwest Biotherapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces